Matthew J. Frank

3.6k total citations
72 papers, 767 citations indexed

About

Matthew J. Frank is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Matthew J. Frank has authored 72 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Oncology, 21 papers in Immunology and 19 papers in Pathology and Forensic Medicine. Recurrent topics in Matthew J. Frank's work include CAR-T cell therapy research (45 papers), Lymphoma Diagnosis and Treatment (19 papers) and Immune Cell Function and Interaction (10 papers). Matthew J. Frank is often cited by papers focused on CAR-T cell therapy research (45 papers), Lymphoma Diagnosis and Treatment (19 papers) and Immune Cell Function and Interaction (10 papers). Matthew J. Frank collaborates with scholars based in United States, Taiwan and Germany. Matthew J. Frank's co-authors include David B. Miklos, Steven Long, Debra K. Czerwinski, Ronald Levy, Albert F. Candia, Richard T. Hoppe, Patrick M. Reagan, Nancy L. Bartlett, Robert S. Janssen and Leo I. Gordon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Matthew J. Frank

61 papers receiving 751 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Matthew J. Frank 522 247 192 162 106 72 767
Sanfang Tu 582 1.1× 201 0.8× 297 1.5× 71 0.4× 144 1.4× 52 858
Chenggong Li 399 0.8× 106 0.4× 247 1.3× 46 0.3× 106 1.0× 36 566
Maria-Elisabeth Goebeler 803 1.5× 438 1.8× 268 1.4× 113 0.7× 163 1.5× 27 1.1k
Nicholas Shinners 313 0.6× 407 1.6× 214 1.1× 136 0.8× 74 0.7× 19 743
Lekha Mikkilineni 783 1.5× 236 1.0× 400 2.1× 48 0.3× 197 1.9× 26 980
Kathleen Gallagher 633 1.2× 195 0.8× 196 1.0× 81 0.5× 212 2.0× 32 837
Kathryn M. Cappell 1.0k 2.0× 420 1.7× 587 3.1× 102 0.6× 249 2.3× 16 1.4k
Mark A. Murakami 198 0.4× 174 0.7× 282 1.5× 83 0.5× 138 1.3× 30 909
Thomas Nerreter 853 1.6× 327 1.3× 387 2.0× 48 0.3× 322 3.0× 24 1.1k
Ian R. Hardy 423 0.8× 161 0.7× 185 1.0× 59 0.4× 241 2.3× 10 556

Countries citing papers authored by Matthew J. Frank

Since Specialization
Citations

This map shows the geographic impact of Matthew J. Frank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Frank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Frank more than expected).

Fields of papers citing papers by Matthew J. Frank

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew J. Frank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Frank. The network helps show where Matthew J. Frank may publish in the future.

Co-authorship network of co-authors of Matthew J. Frank

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Frank. A scholar is included among the top collaborators of Matthew J. Frank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Frank. Matthew J. Frank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sahaf, Bita, Lekha Mikkilineni, Sebastian Fernandez‐Pol, et al.. (2025). Fatal recurrence of IEC-HS after autologous stem cell boost in patients receiving BCMA-CAR T-cell therapy. Blood Advances. 9(15). 3832–3836.
2.
Srinagesh, Hrishikesh K., Anne Marijn Kramer, John H. Baird, et al.. (2025). Clinical and Cytokine Features of Immune Effector Cell–Associated Hemophagocytic Lymphohistiocytosis–Like Syndrome. Blood Cancer Discovery. 7(2). 225–233.
3.
Goyal, Anmol, Alexandria Jensen, Jonathan Alexánder, et al.. (2025). Lisocabtagene Maraleucel for Richter's Transformation—A Case Series. eJHaem. 6(2). e270011–e270011.
4.
Kramer, Anne Marijn, Yiyun Chen, Hrishikesh K. Srinagesh, et al.. (2024). CD22-Directed CAR T Cell Single Cell Multiomic Features Associated with Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS). Blood. 144(Supplement 1). 911–911.
5.
Nie, Esther H., Yi‐Jiun Su, John H. Baird, et al.. (2024). Clinical features of neurotoxicity after CD19 CAR T-cell therapy in mantle cell lymphoma. Blood Advances. 8(6). 1474–1486. 6 indexed citations
6.
Younes, Sheren, Shuchun Zhao, Robbie G. Majzner, et al.. (2023). Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance. Modern Pathology. 36(10). 100256–100256. 10 indexed citations
7.
Spinner, Michael A., R. Alejandro Sica, John Tamaresis, et al.. (2023). Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents. Blood. 141(22). 2727–2737. 10 indexed citations
8.
Dean, Erin, Matthew J. Frank, Nasheed Hossain, et al.. (2023). Circulating tumor DNA adds specificity to PET after axicabtagene ciloleucel in large B-cell lymphoma. Blood Advances. 7(16). 4608–4618. 16 indexed citations
9.
Su, Yi‐Jiun, Mark Hamilton, Neha Agarwal, et al.. (2023). Post-CAR-T Minimal Residual Disease (MRD) Monitoring in Mantle Cell Lymphoma Enables Early Relapse Detection. Blood. 142(Supplement 1). 1673–1673. 1 indexed citations
10.
11.
Nie, Esther H., Saman Ahmadian, Lehi Acosta-Alvarez, et al.. (2023). Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphoma. Journal of Neuropathology & Experimental Neurology. 82(2). 160–168. 7 indexed citations
12.
Frank, Matthew J., Nasheed Hossain, Ali Bukhari, et al.. (2021). Monitoring of Circulating Tumor DNA Improves Early Relapse Detection After Axicabtagene Ciloleucel Infusion in Large B-Cell Lymphoma: Results of a Prospective Multi-Institutional Trial. Journal of Clinical Oncology. 39(27). 3034–3043. 87 indexed citations
13.
Cusatis, Rachel, Irena Tan, Juliana Craig, et al.. (2021). Worsening Financial Toxicity Among Patients Receiving Chimeric Antigen Receptor t-Cell (CAR-T) Therapy: A Mixed Methods Longitudinal Study. Blood. 138(Supplement 1). 567–567. 15 indexed citations
14.
Liang, Emily C., Lori Muffly, Parveen Shiraz, et al.. (2021). Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(5). 405.e1–405.e6. 5 indexed citations
15.
Muffly, Lori, Parveen Shiraz, Judith A. Shizuru, et al.. (2021). Stem Cell Mobilization in Multiple Myeloma: Comparing Safety and Efficacy of Cyclophosphamide +/- Plerixafor versus Granulocyte Colony-Stimulating Factor +/- Plerixafor in the Lenalidomide Era. Transplantation and Cellular Therapy. 27(7). 590.e1–590.e8. 12 indexed citations
16.
Shree, Tanaya, Michael S. Khodadoust, Debra K. Czerwinski, et al.. (2019). A Phase I/II Trial of Intratumoral CpG, Local Low-Dose Radiation, and Oral Ibrutinib in Patients with Low-Grade B-Cell Lymphoma. Blood. 134(Supplement_1). 2825–2825. 2 indexed citations
17.
Frank, Matthew J., Patrick M. Reagan, Nancy L. Bartlett, et al.. (2018). In Situ Vaccination with a TLR9 Agonist and Local Low-Dose Radiation Induces Systemic Responses in Untreated Indolent Lymphoma. Cancer Discovery. 8(10). 1258–1269. 142 indexed citations
18.
Hossain, Nasheed, Bita Sahaf, Jay Y. Spiegel, et al.. (2018). Phase I Experience with a Bi-Specific CAR Targeting CD19 and CD22 in Adults with B-Cell Malignancies. Blood. 132(Supplement 1). 490–490. 48 indexed citations
19.
Frank, Matthew J., Andy Huang, Sai-Wen Tang, et al.. (2017). A Novel Antibody-Cell Conjugation Method to Enhance Cellular Therapies for the Treatment of Hematological Malignancies. Blood. 130. 1532–1532. 1 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanfang Tu Breakdown of academic impact, for papers by Chenggong Li Breakdown of academic impact, for papers by Maria-Elisabeth Goebeler Breakdown of academic impact, for papers by Nicholas Shinners Breakdown of academic impact, for papers by Lekha Mikkilineni Breakdown of academic impact, for papers by Kathleen Gallagher Breakdown of academic impact, for papers by Kathryn M. Cappell Breakdown of academic impact, for papers by Mark A. Murakami Breakdown of academic impact, for papers by Thomas Nerreter Breakdown of academic impact, for papers by Ian R. Hardy
Rankless by CCL
2026